- Home
- PRME vs CNC Comparison
PRME vs CNC Comparison
Compare PRME & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- CNC
- Stock Information
- Founded
- PRME 2019
- CNC 1984
- Country
- PRME United States
- CNC United States
- Employees
- PRME N/A
- CNC N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- CNC Medical Specialities
- Sector
- PRME Health Care
- CNC Health Care
- Exchange
- PRME Nasdaq
- CNC Nasdaq
- Market Cap
- PRME 693.5M
- CNC 14.3B
- IPO Year
- PRME 2022
- CNC 2001
- Fundamental
- Price
- PRME $5.39
- CNC $34.12
- Analyst Decision
- PRME Buy
- CNC Hold
- Analyst Count
- PRME 6
- CNC 16
- Target Price
- PRME $8.88
- CNC $37.07
- AVG Volume (30 Days)
- PRME 4.1M
- CNC 9.8M
- Earning Date
- PRME 11-11-2025
- CNC 10-29-2025
- Dividend Yield
- PRME N/A
- CNC N/A
- EPS Growth
- PRME N/A
- CNC N/A
- EPS
- PRME N/A
- CNC 4.07
- Revenue
- PRME $4,961,000.00
- CNC $159,673,000,000.00
- Revenue This Year
- PRME $179.58
- CNC $30.96
- Revenue Next Year
- PRME N/A
- CNC N/A
- P/E Ratio
- PRME N/A
- CNC $8.45
- Revenue Growth
- PRME 739.42
- CNC 10.73
- 52 Week Low
- PRME $1.11
- CNC $25.08
- 52 Week High
- PRME $6.94
- CNC $70.11
- Technical
- Relative Strength Index (RSI)
- PRME 49.51
- CNC 45.25
- Support Level
- PRME $4.93
- CNC $33.00
- Resistance Level
- PRME $6.30
- CNC $36.53
- Average True Range (ATR)
- PRME 0.61
- CNC 1.23
- MACD
- PRME -0.16
- CNC -0.50
- Stochastic Oscillator
- PRME 24.16
- CNC 17.83
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.